APEN - Apollo Endosurgery, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
2.9500
-0.1400 (-4.53%)
At close: 2:17PM EDT
Stock chart is not supported by your current browser
Previous Close3.0900
Open3.0500
Bid2.7600 x 1400
Ask4.0600 x 1400
Day's Range2.7850 - 3.0800
52 Week Range2.5200 - 6.5900
Volume4,730
Avg. Volume16,407
Market Cap64.703M
Beta (3Y Monthly)0.98
PE Ratio (TTM)N/A
EPS (TTM)-1.8110
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.25
Trade prices are not sourced from all markets
  • ACCESSWIRE

    MicroCap Rodeo Investor Conference - Lineup for October 15 and 16, 2019

    AUSTIN, TX / ACCESSWIRE / October 15, 2019 / The MicroCap Rodeo's inaugural event is set for October 15, and 16 th , 2019 in Austin Texas at the Hilton downtown Austin. Focused on the best ideas concept, ...

  • ACCESSWIRE

    MicroCap Rodeo Investor Conference Lineup for October 15 and 16, 2019

    AUSTIN, TX / ACCESSWIRE / October 15, 2019 / The MicroCap Rodeo's inaugural event is set for October 15, and 16 th , 2019 in Austin Texas at the Hilton downtown Austin. Focused on the best ideas concept, ...

  • Business Wire

    Apollo Endosurgery Receives 510(k) Clearance for Polypropylene Suture-Anchor Assembly

    Apollo Endosurgery, Inc. (“Apollo”) (APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Polypropylene Suture-Anchor Assembly for use specifically with the OverStitch™ Endoscopic Suturing Systems. This proprietary suture-anchor implant is used as part of Apollo’s OverStitch™ and OverStitch Sx™ Endoscopic Suturing Systems to pass and anchor suture in the gastrointestinal tract. Apollo is currently distributing a suture anchor that is manufactured by a third party according to Apollo design specifications.

  • Business Wire

    Apollo Endosurgery, Inc. Reports Second Quarter 2019 Results

    Apollo Endosurgery, Inc. , a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the second quarter ended June 30, 2019.

  • ACCESSWIRE

    Apollo Endosurgery, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / July 23, 2019 / Apollo Endosurgery, Inc. (NASDAQ: APEN ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 23, 2019 at 4:30 ...

  • What Investors Should Know About Apollo Endosurgery, Inc.'s (NASDAQ:APEN) Financial Strength
    Simply Wall St.

    What Investors Should Know About Apollo Endosurgery, Inc.'s (NASDAQ:APEN) Financial Strength

    Apollo Endosurgery, Inc. (NASDAQ:APEN) is a small-cap stock with a market capitalization of US$69m. While investors...

  • Business Wire

    Apollo Endosurgery Announces Completion of Patient Enrollment for the Multi-Center ESG Randomized Interventional Trial (MERIT)

    Apollo Endosurgery, Inc. (“Apollo”) (APEN), a leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the final patient has been enrolled in the Multi-Center ESG Randomized Interventional Trial (MERIT). The US based, prospective randomized multi-center-controlled trial is evaluating the effectiveness of the endoscopic sleeve gastroplasty (“ESG”) procedure. ESG is an endoscopic minimally invasive weight loss procedure based on full-thickness endoscopic suturing using Apollo’s OverStitch™ device.

  • Business Wire

    Apollo Endosurgery, Inc. to Present at the JMP Securities 2019 Life Sciences Conference

    Apollo Endosurgery, Inc. , a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today that company management is scheduled to present at the JMP Securities 2019 Life Sciences Conference being held June 19-20, 2019 at the St.

  • Business Wire

    Apollo Endosurgery Announces US Labeling Update on the ORBERA® Intragastric Balloon System

    Apollo Endosurgery, Inc. (“Apollo”) (APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures announced today that it has received FDA approval for its proposed labeling updates for the ORBERA® Intragastric Balloon System. The goal of the labeling updates is to improve patient safety and these will take effect immediately. The labeling updates improve patient safety by providing further definition and guidance on the appropriate use of the ORBERA® Intragastric Balloon System and patient selection.

  • Volatility 101: Should Apollo Endosurgery (NASDAQ:APEN) Shares Have Dropped 48%?
    Simply Wall St.

    Volatility 101: Should Apollo Endosurgery (NASDAQ:APEN) Shares Have Dropped 48%?

    Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. But if...

  • Business Wire

    Apollo Endosurgery Announces DDW 2019 Clinical Highlights

    Apollo Endosurgery, Inc. , a leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced highlights from DDW 2019 which took place from May 18th to May 21st in San Diego.

  • Business Wire

    Apollo Endosurgery to Participate in Digestive Disease Week® 2019

    Apollo Endosurgery, Inc. (“Apollo”) (APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today its participation during Digestive Disease Week 2019 (“DDW”). Apollo’s OverStitch™ Endoscopic Suturing System and ORBERA® Intragastric Balloon, will be featured in 40 clinical presentations that demonstrate the effectiveness of OverStitch and ORBERA when used across a number of diverse clinical needs. Apollo will also feature Overstitch Sx, its latest endoscopic suturing device designed for compatibility with single-channel endoscopes with diameters ranging from 8.8mm to 9.8mm.

  • Business Wire

    Apollo Endosurgery, Inc. Reports First Quarter 2019 Results

    Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET

  • Business Wire

    Apollo Endosurgery, Inc. to Report First Quarter Results on May 2, 2019

    Apollo Endosurgery, Inc. , a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the first quarter ended March 31, 2019 on Thursday, May 2, 2019, after the U.S.

  • Apollo Endosurgery (APEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
    Zacks

    Apollo Endosurgery (APEN) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

    Apollo Endosurgery (APEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Did Apollo Endosurgery, Inc. (NASDAQ:APEN) Insiders Buy Up More Shares?
    Simply Wall St.

    Did Apollo Endosurgery, Inc. (NASDAQ:APEN) Insiders Buy Up More Shares?

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunatel...

  • Business Wire

    Apollo Endosurgery Appoints John Barr to Board of Directors

    The Board of Directors of Apollo Endosurgery, Inc. (“Apollo”) (APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that John Barr has been appointed to Apollo’s Board of Directors as an independent director, effective immediately. Mr. Barr will join 9 other directors, a majority of whom are independent under the rules and regulations of the United States Securities and Exchange Commission, and will serve as a member of the Audit and Nominating and Governance Committees. “John is a highly accomplished leader in the medical device field and an experienced board member who brings a wealth of executive leadership skills and experience to our board,” said Rich Meelia, Chairman of Apollo’s Board of Directors.

  • Business Wire

    Apollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2018 Results

    Conference Call to Discuss Results Today at 7:30 a.m. CT / 8:30 a.m. ET

  • Business Wire

    Apollo Endosurgery, Inc. to Report Fourth Quarter Results on March 18, 2019

    Apollo Endosurgery, Inc. , a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Company is scheduled to release its financial results for the fourth quarter ended December 31, 2018 on Monday, March 18, 2019, before the U.S.

  • Does Market Volatility Impact Apollo Endosurgery, Inc.’s (NASDAQ:APEN) Share Price?
    Simply Wall St.

    Does Market Volatility Impact Apollo Endosurgery, Inc.’s (NASDAQ:APEN) Share Price?

    Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! If you own shares in Apollo Endosurgery, Inc. (NASDAQ:APEN) thenRead More...

  • Business Wire

    Apollo Endosurgery Announces Publication of Outcomes of Endoscopic Sleeve Gastroplasty (ESG) in 1,000 Consecutive Patients

    Apollo Endosurgery, Inc. , a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced the publication of Outcomes of Endoscopic Gastroplasty in 1,000 Consecutive Patients from a single center - King Saud University, Riyadh, Saudi Arabia featured in Gastrointestinal Endoscopy - https://doi.org/10.1016/j.gie.2018.12.012.